rxstat › Classes › Immunostimulants

Immunostimulants: shortage status in Canada

2 of the 10 immunostimulants rxstat tracks are currently in shortage in Canada, including 1 designated Tier 3 (most serious) by Health Canada. When one drug in a class is short, demand often shifts to its alternatives, so related drugs can tighten too; each page below shows which manufacturers are affected and the latest recovery estimates.

Peginterferon Alfa-2a (Pegasys) Widespread shortage 1 of 1 reported products affected · est. return Sep 30, 2026 Bacillus Calmette-guerin (Oncotice) Partial shortage 1 of 1 reported products affected · est. return Dec 31, 2027 Aldesleukin (Proleukin) No current shortage Bacillus Calmette-guerin (Immucyst) Discontinued 0 of 1 reported products affected Filgrastim (Neupogen) No current shortage Glatiramer No current shortage Interferon Alfa-2b (Intron A) Discontinued 0 of 5 reported products affected Peginterferon Alfa-2b Ribavirin (Pegetron) Discontinued 0 of 6 reported products affected Plerixafor (Mozobil) No current shortage Water Interferon Alfa-2b (Intron A) Discontinued 0 of 2 reported products affected

Guides: what to do when your medication is in shortage · how to read these statuses

Class groupings follow the WHO ATC classification in Health Canada's reports. Data reflects manufacturer mandatory filings; see methodology.